IGF1 and hepatocellular carcinoma: While β-catenin activation may cooperate with non-canonical pathways such as insulin/IGF-1/IRS-1/MAPK during hepatocarcinogenesis in mice [47], our study on sorafenib-induced apoptosis in HCC cell lines reveals the involvement of β-catenin and MAPK/AP-1.